U:  P:        Forgot Password? Username?

Physician Registration


medical_05


Current Trials

Gastrointestinal Crohn's Disease NURTURE, the Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents
NURTURE, the Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents PDF Print E-mail
  • The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics, and immunogenicity of certolizumab pegol treatment in pediatric patients, aged 6 to 17, with moderately to severe active Crohn's disease. The target enrollment is 160 patients.

 

< Prev   Next >
 
Privacy PolicyTerms of ServiceLogin